{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:27:20Z","timestamp":1789986440201,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.vaccine.2007.04.032","type":"journal-article","created":{"date-parts":[[2007,5,16]],"date-time":"2007-05-16T12:46:03Z","timestamp":1179319563000},"page":"A3-A7","source":"Crossref","is-referenced-by-count":61,"special_numbering":"S1","title":["Meningitis epidemics in Africa: A brief overview"],"prefix":"10.1016","volume":"25","author":[{"given":"R\u00e9my","family":"Teyssou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwan","family":"Muros-Le Rouzic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2007.04.032_bib1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1699-0463.1998.tb01379.x","article-title":"Population genetics and molecular epidemiology of Neisseria meningitidis","volume":"106","author":"Caugant","year":"1998","journal-title":"APMIS"},{"issue":"6","key":"10.1016\/j.vaccine.2007.04.032_bib2","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1073\/pnas.95.6.3140","article-title":"Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms","volume":"95","author":"Maiden","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2007.04.032_bib3","first-page":"1","article-title":"La m\u00e9ningite c\u00e9r\u00e9brospinale en Afrique","volume":"28","author":"Lapeyssonnie","year":"1963","journal-title":"Bull World Health Organ"},{"issue":"10","key":"10.1016\/j.vaccine.2007.04.032_bib4","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3201\/eid0910.030182","article-title":"Environmental risk and meningitis epidemics in Africa","volume":"9","author":"Molesworth","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2007.04.032_bib5","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1128\/IAI.60.12.5267-5282.1992","article-title":"Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China","volume":"60","author":"Wang","year":"1992","journal-title":"Infect Immun"},{"issue":"8657","key":"10.1016\/j.vaccine.2007.04.032_bib6","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(89)90439-X","article-title":"Intercontinental spread of an epidemic group A Neisseria meningitidis strain","volume":"2","author":"Moore","year":"1989","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2007.04.032_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/infdis\/165.1.53","article-title":"A comparison of the variable antigens expressed by clone IV-1 and subgroup III of Neisseria meningitidis serogroup A","volume":"165","author":"Achtman","year":"1992","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2007.04.032_bib8","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3201\/eid0705.010513","article-title":"Clonal Expansion of Sequence Type (ST-)5 and Emergence of ST-7 in Serogroup A Meningococci, Africa","volume":"7","author":"Nicolas","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2007.04.032_bib9","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1073\/pnas.061386098","article-title":"Fit genotypes and escape variants of subgroup III Neisseria meningitidis during three pandemics of epidemic meningitis","volume":"98","author":"Zhu","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"10.1016\/j.vaccine.2007.04.032_bib10","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1001\/jama.260.18.2686","article-title":"Group A meningococcal carriage in travelers returning from Saudi Arabia","volume":"260","author":"Moore","year":"1988","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.vaccine.2007.04.032_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1017\/S095026880005233X","article-title":"Epidemics of serogroup A Neisseria meningitidis of subgroup III in Africa, 1989\u201394","volume":"116","author":"Guibourdenche","year":"1996","journal-title":"Epidemiol Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2007.04.032_bib12","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3201\/eid0703.017309","article-title":"Molecular epidemiology of serogroup A meningitis in Moscow, 1969 to 1997","volume":"7","author":"Achtman","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2007.04.032_bib13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s15010-002-3012-2","article-title":"A critical review of control strategies against meningococcal meningitis epidemics in sub-Saharan African countries","volume":"30","author":"Chippaux","year":"2002","journal-title":"Infection"},{"issue":"9","key":"10.1016\/j.vaccine.2007.04.032_bib14","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1046\/j.1365-3156.1998.00300.x","article-title":"Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitidis in West Africa","volume":"3","author":"Kwara","year":"1998","journal-title":"Trop Med Int Health"},{"issue":"6","key":"10.1016\/j.vaccine.2007.04.032_bib15","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/0035-9203(86)90303-2","article-title":"The efficacy of meningococcal polysaccharide vaccine in preventing group A meningococcal disease in The Gambia, West Africa","volume":"80","author":"Greenwood","year":"1986","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"12","key":"10.1016\/j.vaccine.2007.04.032_bib16","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1046\/j.1360-2276.2003.01126.x","article-title":"Outbreaks of serogroup X meningococcal meningitis in Niger 1995\u20132000","volume":"8","author":"Djibo","year":"2003","journal-title":"Trop Med Int Health"},{"issue":"11","key":"10.1016\/j.vaccine.2007.04.032_bib17","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1086\/340414","article-title":"Outbreak of W135 Meningococcal Disease in 2000: Not Emergence of a New W135 Strain but Clonal Expansion within the Electophoretic Type-37 Complex","volume":"185","author":"Mayer","year":"2002","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2007.04.032_bib18","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1128\/JCM.40.3.1083-1084.2002","article-title":"Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger","volume":"40","author":"Taha","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.04.032_bib19","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3201\/eid0604.000423","article-title":"Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex","volume":"6","author":"Popovic","year":"2000","journal-title":"Emerg Infect Dis"},{"issue":"18","key":"10.1016\/j.vaccine.2007.04.032_bib20","first-page":"152","article-title":"Meningococcal disease, serogroup W135, Burkina Faso. Preliminary report, 2002","volume":"77","author":"Anonymous","year":"2002","journal-title":"Wkly Epidemiol Rec"},{"issue":"6","key":"10.1016\/j.vaccine.2007.04.032_bib21","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/infdis\/167.6.1320","article-title":"Antigenic and epidemiologic properties of the ET-37 complex of Neisseria meningitidis","volume":"167","author":"Wang","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.04.032_bib22","unstructured":"European Union Invasive Bacterial Infections Surveillance (EU-IBIS), Meningococci Network. Surveillance network for invasive Neisseria meningitidis in Europe-1999 & 2000. (available at http:\/\/www.euibis.org\/documents\/meningo19992000.pdf)."},{"key":"10.1016\/j.vaccine.2007.04.032_bib23","unstructured":"European Union Invasive Bacterial Infections Surveillance (EU-IBIS) Meningococci Network. Invasive Neisseria meningitidis in Europe-2001 (available at http:\/\/www.euibis.org\/documents\/EU_IBISmeningococci 2001reportFINALDRAFT.pdf)."},{"issue":"5","key":"10.1016\/j.vaccine.2007.04.032_bib24","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.273.5.390","article-title":"The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992: Emergence of a virulent clone of Neisseria meningitidis","volume":"273","author":"Whalen","year":"1995","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.vaccine.2007.04.032_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1046\/j.1440-1754.2001.00679.x","article-title":"Meningococcal disease and vaccination in North America","volume":"37","author":"Pollard","year":"2001","journal-title":"J Paediatr Child Health"},{"issue":"3","key":"10.1016\/j.vaccine.2007.04.032_bib26","first-page":"17","article-title":"Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 1999, through 31 December, 2001","volume":"30","author":"Squires","year":"2004","journal-title":"Can Commun Dis Rep"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2007.04.032_bib27","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0264-410X(01)00299-7","article-title":"Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story","volume":"20","author":"Miller","year":"2001","journal-title":"Vaccine"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2007.04.032_bib28","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0264-410X(02)00589-3","article-title":"Impact of mass vaccination with polysaccharide conjugate vaccine against serogroup C meningococcal disease in Spain","volume":"21","author":"Salleras","year":"2003","journal-title":"Vaccine"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2007.04.032_bib29","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0264-410X(02)00590-X","article-title":"Dramatic decline of serogroup C meningococcal disease in Catalonia (Spain) after a mass vaccination campaign with meningococcal C conjugated vaccine","volume":"21","author":"Salleras","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.04.032_bib30","unstructured":"Epidemiology of meningococcal C disease in Belgium one year after a mass immunization campaign. Abstracts of the 7th European monitoring group on Meningococci (EMGM), Lanzarote, Spain, September 24\u201327, 2003: 2003."},{"issue":"23","key":"10.1016\/j.vaccine.2007.04.032_bib31","first-page":"1132","article-title":"The first effect of the national vaccination campaign against meningococcal-C disease: a rapid and sharp decrease in the number of patients","volume":"147","author":"de Greeff","year":"2003","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.vaccine.2007.04.032_bib32","unstructured":"Anonymous. An advisory committee statement (ACS). National advisory committee on immunization (NACI). Supplementary statement on conjugate meningococcal vaccines. Can Commun Dis Rep 2003; 29(ACS-6):10\u201311."},{"key":"10.1016\/j.vaccine.2007.04.032_bib33","unstructured":"Risk of epidemic meningitis in Africa: a cause for concern ; WER, N\u00b010, 9 March 2007."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07004574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07004574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T01:41:17Z","timestamp":1587519677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07004574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":33,"alternative-id":["S0264410X07004574"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.04.032","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}